TSX:AEZS - Post Discussion
Post by
prophetoffactz on Jun 29, 2024 11:17pm
Top-line diagnostic results
AEZS's pediatric clinical trial completed its last patient last visit 16 days ago with top-line results expected in Q3 2024.
AEZS's adult clinical trial was completed
2016-11-29 according to clinicaltrials.gov: Study Details | Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency | ClinicalTrials.gov Top-line results for the adult trial were reported 36 days later in a news release:
2017-01-04 | Aeterna Zentaris Announces Top-Line Results of Confirmatory Phase 3 Trial of Macrilen™ | TSX:AEZS | Press Release (stockhouse.com) The 36 days to report the top-line adult clinical trial results may have been complicated by Christmas and New Year's holidays.
Assuming it takes 30-36 days to report the pediatric top-line results, given that it has been 16 days since the last patient last visit, it may be possible that we see the top-line results for the pediatric trial in 2-3 weeks. That puts it potentially right around the time of the AGM on July 16, 2024.
Be the first to comment on this post